ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Oral Microbes and Host

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1591285

This article is part of the Research TopicDiabetes and Oral HealthView all 5 articles

Salivary microbiota and IgA responses are different in pre-diabetic individuals compared to normoglycemic controls

Provisionally accepted
Nahoko  Kato-KogoeNahoko Kato-Kogoe1*Kouji  TsudaKouji Tsuda1Asako  KudoAsako Kudo1Shoichi  SakaguchiShoichi Sakaguchi1Michi  OmoriMichi Omori1Eri  KomoriEri Komori1Mayu  OhmichiMayu Ohmichi1Wataru  HamadaWataru Hamada1Shota  NakamuraShota Nakamura2Takashi  NakanoTakashi Nakano1Junko  TamakiJunko Tamaki1Takaaki  UenoTakaaki Ueno1
  • 1Osaka Medical and Pharmaceutical University, Takatsuki City, Japan
  • 2Osaka University, Suita, Ōsaka, Japan

The final, formatted version of the article will be published soon.

In recent years, changes in the oral microbiota of patients with type 2 diabetes mellitus (T2DM) have been increasingly recognized. The salivary microbiota may also be altered in prediabetes, which is the earliest stage of abnormal blood glucose regulation and a reversible stage preceding T2DM; however, its characteristics are poorly understood. Salivary immunoglobulin A (IgA) is a host defense factor central to the oral immune system and may play an important role in regulating the salivary microbiota. Given that alterations in immunoreactivity are observed in prediabetes, we hypothesized that the salivary IgA response may also be altered; however, limited knowledge exists regarding this. Therefore, in the present study, we aimed to evaluate the characteristics of salivary microbiota and IgA responses against salivary microbiota in individuals with pre-diabetes, comparing them to those in individuals with normoglycemia.Methods: Saliva samples were collected from 101 pre-diabetic individuals (PreDM group) and 101 age-and sex-matched normoglycemic controls (Normal group). Further, 16S rRNA metagenomic analysis was performed to compare bacterial microbiota composition. For each of the 19 saliva samples from the PreDM and Normal groups, IgA-enriched and IgA-nonenriched fractions were separated via magnetic-activated cell sorting, followed by 16S rRNA metagenomic analysis. The IgA index was calculated to evaluate the difference in the IgA response to each bacterium between the PreDM and Normal groups.Results: Bacterial species richness was significantly lower in the PreDM group than in the Normal group (observed operational taxonomic unit index, p = 0.042), and a difference between these groups was noted in the overall salivary microbiota structure (unweighted UniFrac distances, p = 0.009).Salivary IgA responses against several bacterial genera differed between the PreDM and Normal groups. Significantly higher IgA responses were noted against Haemophilus in the PreDM group, with lower responses against Capnocytophaga, Corynebacterium, and Streptococcus relative to those in the 3 Normal group. Conclusions: Salivary microbiota and IgA responses differ between pre-diabetic individuals and normoglycemic controls. The current findings advance our understanding of the interaction between oral bacteria and host immune responses in patients with a poor glycemic status.

Keywords: Pre-diabetes, microbiota, Saliva, Immunoglobulin A, 16S rRNA, IgA-seq

Received: 10 Mar 2025; Accepted: 16 May 2025.

Copyright: © 2025 Kato-Kogoe, Tsuda, Kudo, Sakaguchi, Omori, Komori, Ohmichi, Hamada, Nakamura, Nakano, Tamaki and Ueno. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Nahoko Kato-Kogoe, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.